Humoral and Cellular Response Following Vaccination

A special issue of Vaccines (ISSN 2076-393X).

Deadline for manuscript submissions: closed (15 March 2024) | Viewed by 311

Special Issue Editor


E-Mail Website
Guest Editor
Lincoln Laboratory, Massachusetts Institute of Technology, Cambridge, MA, USA
Interests: SARS-CoV-2 infection; antibodies; vaccines
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The COVID-19 pandemic is an ongoing global crisis, with over 6 million deaths and 550 million cases worldwide.

Since December 2020, several vaccines against this disease have been approved and distributed worldwide.

As the COVID-19 pandemic continues, issues related to these vaccines are still abundant and relevant. These issues include vaccine effectiveness, boosters, adverse events post-vaccination, breakthrough infections, reinfections, and chronic COVID.

The aim of this issue is to collect contributions on humoral and cellular responses related to COVID-19 vaccines to better inform future vaccine designs, boosters, and enhancements and the minimization of adverse events.

Dr. Darrell O. Ricke
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • COVID-19
  • vaccines
  • vaccination
  • public health
  • pandemic

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop